Genomic control of inflammation in experimental atopic dermatitis

Atopic Dermatitis (AD) or eczema, a recurrent allergic inflammation of the skin, afflicts 10–20% of children and 5% adults of all racial and ethnic groups globally. We report a new topical treatment of AD by a Nuclear Transport Checkpoint Inhibitor (NTCI), which targets two nuclear transport shuttle...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Zienkiewicz, Jozef, Qiao, Huan, Gibson-Corley, Katherine N., Boyd, Kelli L., Veach, Ruth Ann, Hawiger, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640569/
https://www.ncbi.nlm.nih.gov/pubmed/36344555
http://dx.doi.org/10.1038/s41598-022-23042-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640569/
https://www.ncbi.nlm.nih.gov/pubmed/36344555
http://dx.doi.org/10.1038/s41598-022-23042-x

Ejemplares similares